OGEN
OGEN
AMEX · Biotechnology

Oragenics Inc

$0.53
-0.01 (-1.16%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +869.6% upside
Low Target $3.59
Average Target $5.14
High Target $6.80
Current Price $0.53
Current
$0.53
Target
$5.14
$3.59 $5.14 avg $6.80
Scenario Analysis
Bear Case
$3.59
577.2%
Low target
Base Case
$5.14
+869.6%
Avg target
Bull Case
$6.80
+1,182.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$1.45
-63.4% from high
52-Week Low
$0.48
+10.4% from low
Target vs 52W High
$5.14
+254.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +2.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -15.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.5%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.6%